| Literature DB >> 2736504 |
J Jacob1, H Brune, G Gettbarn, D Grimmer, U Heinrich, E Mohtashamipur, K Norpoth, F Pott, R Wenzel-Hartung.
Abstract
The urinary and faecal excretion of pyrene and 1-hydroxypyrene after oral (53.4%), intraperitoneal (3.1%), intratracheal (30-37%) and intrapulmonary application (0.003%) to rats has been determined by means of gas chromatography/mass spectrometry and the excretion rates were found to depend on the mode of application. With regard to the low urinary excretion rates, 1-hydroxypyrene seems not to be very suitable as a biological marker for PAH exposure to man.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2736504 DOI: 10.1016/0304-3835(89)90209-7
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679